| HOME >> BIOLOGY >> TECHNOLOGY |
Web site includes searchable database of biotech contract service providers
INDIANAPOLIS, Feb. 28 /PRNewswire/ -- BioCrossroads, Indiana's initiative to grow the life sciences, has released an extensive report on major developments within the pharmaceutical and biotechnology industries holding significant promise for Indiana's continued life sciences growth. In addition, the initiative has launched a new Web site -- http://www.biocrossroadslinx.com -- offering a searchable database of comprehensive information about biopharma contract service providers and related university programs.
The 40-page report researches and spotlights the trend that, to combat the high costs and long lead times of product development and to manage scientific and business risks, both pharmaceutical and biotechnology companies are increasingly utilizing third party contract service providers (CSPs) as strategic partners for outsourced services necessary to bring a product to market. These services cover a wide range of drug development activities, including analytical testing, toxicology, clinical trial materials manufacturing, and regulatory consulting.
With the basic industry business model shifting from the traditional
fully-integrated pharmaceutical company (FIPCO) that did everything from
discovery to commercialization in house to a new "FIPNET" model creating a
fully-integrated pharma network of sophisticated service providers, the
opportunities for Indiana companies to expand services, employment and
revenues across this sector are substantial. As the report documents,
Indiana already features more than 40 CSPs serving this growing sector.
Furthermore, of the 128 different activities identified in the report that
advance the drug development process from discovery to commercialization,
Indiana CSPs currently perform 112 of these services (with many planning
additional service offerings within the nex
'/>"/>
| SOURCE BioCrossroads Copyright©2008 PR Newswire. All rights reserved |